Abstract
Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Current Molecular Medicine
Title:The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation
Volume: 17 Issue: 1
Author(s): L. Liu, Y. Wei and X. Wei*
Affiliation:
- Laboratory for Aging Research, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041,China
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Abstract: Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Export Options
About this article
Cite this article as:
Liu L., Wei Y. and Wei X.*, The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation, Current Molecular Medicine 2017; 17 (1) . https://dx.doi.org/10.2174/1566524017666170220102732
DOI https://dx.doi.org/10.2174/1566524017666170220102732 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Midkine in Inflammatory and Toxic Conditions
Current Drug Delivery COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region
Current Diabetes Reviews Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Cardiovascular & Hematological Disorders-Drug Targets Novel Drug Targets in Malaria Parasite with Potential to Yield Antimalarial Drugs with Long Useful Therapeutic Lives
Current Pharmaceutical Design The Role of COX-2 in Acute Pain and the Use of Selective COX-2 Inhibitors for Acute Pain Relief
Current Pharmaceutical Design Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Narrative Review
Current Pediatric Reviews Human Islet Transplantation: Current Status and Future Direction
Micro and Nanosystems Optimal Medical Therapy for Coronary Artery Disease in 2011 – Perspectives from the STICH Trial
Cardiovascular & Hematological Agents in Medicinal Chemistry Overview
Mini-Reviews in Medicinal Chemistry Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders
Current Medicinal Chemistry Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer
Current Pharmaceutical Design Current and Under Development Treatment Modalities of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review
Current Cardiology Reviews Models of Infection Before and After Stroke: Investigating New Targets
Infectious Disorders - Drug Targets A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Synthesis and Biological Evaluation of New Pyrazole-based Thiazolyl Hydrazone Derivatives as Potential Anticancer Agents
Letters in Drug Design & Discovery